Ibalizumab (also known as balizumab-uiyk nd formerly known as TNX-355) is a monoclonal antibody that binds to CD4 receptors on the surface of CD4-positive cells, preventing HIV particle entry into the lymphocytes. It is an advanced and current antibody in development for the treatment of HIV/AIDS. It has been developed by Taimed biologics and Theratechnologies?8,5.
货号（Catalog No.）
CSD00152
通用名INN
Ibalizumab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Ibalizumab (also known as ibalizumab-uiyk and formerly known as TNX-355) is a monoclonal antibody that binds to CD4 receptors on the surface of CD4-positive cells, preventing HIV particle entry into the lymphocytes. It is an advanced and current antibody in development for the treatment of HIV/AIDS. It has been developed by Taimed biologics and Theratechnologies 8,5.
别名(Alternative names)
Hu5A8,TMB-355,TNX-355
靶点;物种(Specificity target name;species)
CD4 D3 domain[Homo sapiens]
种类(Species)
Humanized
受体鉴定(Receptor identification)
IgG4-kappa
化学信息
CAS
680188-33-4
存储条件(Storage)
store at -80°C